Shukla Sanjay

Shukla Sanjay is listed in filings as President and CEO at aTyr Pharma, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to aTyr Pharma, Inc. (ATYR). The current snapshot covers public activity from Jan 10, 2025 to Feb 4, 2026. Reported amounts are shown as $3.7K to $3.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.